Investors are holding back even with the slight tariff reprieve among the lingering trade war uncertainties.

Market Numbers: (Futures)

TSX : Down (1.00%) 24,622.11
TSXV: Flat (0.00%) 607.75
DOW:  Down  (0.87%)  42,693.00
NASDAQ: Up (1.53%) 20,349.00
FTSE: Down (1.07%) 8,661.80

In the Headlines

In a unified response to escalating trade tensions with the U.S., Canada’s first ministers have agreed to reduce interprovincial trade barriers in hopes of strengthening the country’s domestic economy.

And Prime Minister Justin Trudeau is not open to lifting Canada’s full package of retaliatory tariffs if US President Donald Trump leaves any on Canada in place.

Currencies Update: (Futures)

The loonie continues to weaken across the board, losing 0.07% to $.6963 US, slipping 0.37% against the Euro to $0.6413, and Bitcoin just keeps coming up positive, adding a quick 0.19% to $128,959.60

Commodities: (Future)

Natural Gas: Down (1.73%), 4.37
WTI:  Up (0.25%), 66.47
Gold: Down (0.35%), 2,908.57
Copper:  Up (0.75%) 6.27

To stay up-to-date on all of your market news head to stockhouse.com

Join the discussion: Find out what everybody’s saying check out the rest of Stockhouse’s stock forums and message boards.

The material provided in this article is for information only and should not be treated as investment advice. For full disclaimer information, please click here

More From The Market Online
Medicine factory line

Buyout disclosure sends Theratechnologies stock soaring

Future Pak discloses its intention to acquire Theratechnologies (TSX:TH), a biopharmaceutical company focused on oncology and HIV.
Leviathan Gold logo

Michael Gentile adds Leviathan Gold to his portfolio

Michael Gentile, one of Canada's most prominent junior mining investors, takes a stake in explorer Leviathan Gold (TSXV:LVX).
(AI generated stock image.)

Economist insights and financial analysts on the long-term outlook

The economic landscape continues to evolve, influenced by various factors including policy shifts, inflation trends, and market dynamics.
Cancer therapy targeting malignant cell

Small-cap cancer therapy innovator raises $20M in flexible funding

Oncolytics Biotech (TSX:ONC), a cancer therapy developer, announces a US$20M financing with institutional investor Alumni Capital.